91九色视频

header-logo
GettyImages-595518921-hero
Institute for Health & Equity
Liliana Pezzin, PhD, JD

Liliana E. Pezzin, PhD, JD

Professor and Interim Director, Epidemiology & Social Sciences; Executive Director, Collaborative for Healthcare Delivery Science

Locations

  • General Internal Medicine

Contact Information

Biography

Dr. Pezzin is a professor in medicine and is also in the Center for Advancing Population Science at the 91九色视频. She is an economist specializing in applied econometrics and public finance.

Research Interests

Much of Dr. Pezzin’s research effort focuses on issues related to long-term care, aging and disability, with special emphasis on the interplay between public policy and family behavior. She recently concluded work as principal investigator on an NIA-funded grant examining the relationship between state long-term care policies and living and care arrangements of elderly persons, and as the co-principal investigator on another NIA-funded study developing game theoretical models of family long-term care decisions.

Her outcomes research portfolio includes analyses of the effects of patterns of breast cancer care on disease recurrence, mortality, quality of life and economic well-being; analyses of the relationship between guideline adherence, processes of care and outcomes in electrodiagnostic medicine; and two randomized controlled trials of behavioral interventions designed to (i) improve blood pressure control and (ii) self-management and reduce adverse events secondary to complex medication regimens among home health patients. Dr. Pezzin's research projects are funded by NCI, VA-HSR&D, NHLBI and AHRQ, respectively.

Publications

  • (Bickell NA, Nattinger AB, McGinley EL, Schymura MJ, Laud PW, Pezzin LE.) J Clin Oncol. 2025 Jan;43(1):57-64 PMID: 39348624 PMCID: PMC11663124 09/30/2024

  • (Dong Y, Drury R, Spillane J, Lodes MW, Penlesky AC, Hanson R, Pezzin LE, Singh S, Nattinger AB.) J Gen Intern Med. 2024 Oct 02 PMID: 39358501 SCOPUS ID: 2-s2.0-85205436460 10/03/2024

  • (Edelstein AI, Tanenbaum JT, McGinley EL, Dillingham TR, Pezzin LE.) Arthroplast Today. 2024 Jun;27:101356 PMID: 38524153 PMCID: PMC10958215 03/25/2024

  • (Abramoff BA, Hentschel C, Dillingham IA, Dillingham T, Baraniecki-Zwil G, Williams A, Pezzin LE.) PM R. 2024 Jun;16(6):553-562 PMID: 38145343 PMCID: PMC11189756 12/25/2023

  • (Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A.) Blood Cancer J. 2024 May 26;14(1):61 PMID: 38796476 PMCID: PMC11127981 SCOPUS ID: 2-s2.0-85194268737 05/26/2024

  • (McLarney M, Fergestrom N, Zheng J, Pezzin LE.) PM R. 2024 May;16(5):441-448 PMID: 38129994 12/22/2023

  • (Dong Y, Hanson R, Penlesky AC, Nattinger AB, Heinrich TW, Pezzin LE.) WMJ. 2023 Dec;122(5):319-324 PMID: 38180917 SCOPUS ID: 2-s2.0-85181629574 01/05/2024

  • (Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A.) Bone Marrow Transplant. 2023 Dec;58(12):1400-1402 PMID: 37673983 PMCID: PMC11646697 SCOPUS ID: 2-s2.0-85170080925 09/07/2023

  • (Edelstein AI, Dillingham TR, McGinley EL, Pezzin LE.) J Bone Joint Surg Am. 2023 Nov 01;105(21):1695-1702 PMID: 37678258 PMCID: PMC10609704 SCOPUS ID: 2-s2.0-85175741071 09/08/2023

  • (Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE.) J Clin Oncol. 2023 Apr 10;41(11):2067-2075 PMID: 36603178 PMCID: PMC10419674 SCOPUS ID: 2-s2.0-85152169276 01/06/2023

  • (Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN.) Breast Cancer Res Treat. 2023 Jan;197(1):223-233 PMID: 36357711 SCOPUS ID: 2-s2.0-85141681578 11/11/2022

Publications of from the

© 2024 91九色视频.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.